Home > Publications Database > Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy. > print

001     162850
005     20240322115504.0
024 7 _ |a 10.1007/s00401-021-02348-6
|2 doi
024 7 _ |a pmid:34292399
|2 pmid
024 7 _ |a pmc:PMC8423709
|2 pmc
024 7 _ |a 0001-6322
|2 ISSN
024 7 _ |a 1432-0533
|2 ISSN
024 7 _ |a altmetric:110326496
|2 altmetric
037 _ _ |a DZNE-2021-01505
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zimmer, Till S
|b 0
245 _ _ |a Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy.
260 _ _ |a Heidelberg
|c 2021
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1711018301_32504
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Neuronal dysfunction due to iron accumulation in conjunction with reactive oxygen species (ROS) could represent an important, yet underappreciated, component of the epileptogenic process. However, to date, alterations in iron metabolism in the epileptogenic brain have not been addressed in detail. Iron-related neuropathology and antioxidant metabolic processes were investigated in resected brain tissue from patients with temporal lobe epilepsy and hippocampal sclerosis (TLE-HS), post-mortem brain tissue from patients who died after status epilepticus (SE) as well as brain tissue from the electrically induced SE rat model of TLE. Magnetic susceptibility of the presumed seizure-onset zone from three patients with focal epilepsy was compared during and after seizure activity. Finally, the cellular effects of iron overload were studied in vitro using an acute mouse hippocampal slice preparation and cultured human fetal astrocytes. While iron-accumulating neurons had a pyknotic morphology, astrocytes appeared to acquire iron-sequestrating capacity as indicated by prominent ferritin expression and iron retention in the hippocampus of patients with SE or TLE. Interictal to postictal comparison revealed increased magnetic susceptibility in the seizure-onset zone of epilepsy patients. Post-SE rats had consistently higher hippocampal iron levels during the acute and chronic phase (when spontaneous recurrent seizures are evident). In vitro, in acute slices that were exposed to iron, neurons readily took up iron, which was exacerbated by induced epileptiform activity. Human astrocyte cultures challenged with iron and ROS increased their antioxidant and iron-binding capacity, but simultaneously developed a pro-inflammatory phenotype upon chronic exposure. These data suggest that seizure-mediated, chronic neuronal iron uptake might play a role in neuronal dysfunction/loss in TLE-HS. On the other hand, astrocytes sequester iron, specifically in chronic epilepsy. This function might transform astrocytes into a highly resistant, pro-inflammatory phenotype potentially contributing to pro-epileptogenic inflammatory processes.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Astrocytes
|2 Other
650 _ 7 |a Glutathione metabolism
|2 Other
650 _ 7 |a Iron
|2 Other
650 _ 7 |a Status epilepticus
|2 Other
650 _ 7 |a Temporal lobe epilepsy with hippocampal sclerosis
|2 Other
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Astrocytes: metabolism
|2 MeSH
650 _ 2 |a Astrocytes: pathology
|2 MeSH
650 _ 2 |a Case-Control Studies
|2 MeSH
650 _ 2 |a Cell Culture Techniques
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Epilepsy, Temporal Lobe: complications
|2 MeSH
650 _ 2 |a Epilepsy, Temporal Lobe: metabolism
|2 MeSH
650 _ 2 |a Epilepsy, Temporal Lobe: pathology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Hippocampus: metabolism
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Iron: metabolism
|2 MeSH
650 _ 2 |a Iron Metabolism Disorders: etiology
|2 MeSH
650 _ 2 |a Iron Metabolism Disorders: pathology
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Oxidative Stress: physiology
|2 MeSH
650 _ 2 |a Rats
|2 MeSH
650 _ 2 |a Status Epilepticus: complications
|2 MeSH
650 _ 2 |a Status Epilepticus: metabolism
|2 MeSH
650 _ 2 |a Status Epilepticus: pathology
|2 MeSH
700 1 _ |a David, Bastian
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Broekaart, Diede W M
|b 2
700 1 _ |a Schidlowski, Martin
|0 P:(DE-2719)9001203
|b 3
|u dzne
700 1 _ |a Ruffolo, Gabriele
|b 4
700 1 _ |a Korotkov, Anatoly
|b 5
700 1 _ |a van der Wel, Nicole N
|b 6
700 1 _ |a van Rijen, Peter C
|b 7
700 1 _ |a Mühlebner, Angelika
|b 8
700 1 _ |a van Hecke, Wim
|b 9
700 1 _ |a Baayen, Johannes C
|b 10
700 1 _ |a Idema, Sander
|b 11
700 1 _ |a François, Liesbeth
|b 12
700 1 _ |a van Eyll, Jonathan
|b 13
700 1 _ |a Dedeurwaerdere, Stefanie
|b 14
700 1 _ |a Kessels, Helmut W
|b 15
700 1 _ |a Surges, Rainer
|b 16
700 1 _ |a Rüber, Theodor
|b 17
700 1 _ |a Gorter, Jan A
|b 18
700 1 _ |a Mills, James D
|b 19
700 1 _ |a van Vliet, Erwin A
|b 20
700 1 _ |a Aronica, Eleonora
|0 0000-0002-3542-3770
|b 21
773 _ _ |a 10.1007/s00401-021-02348-6
|g Vol. 142, no. 4, p. 729 - 759
|0 PERI:(DE-600)1458410-4
|n 4
|p 729 - 759
|t Acta neuropathologica
|v 142
|y 2021
|x 1432-0533
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/162850/files/DZNE-2021-01505.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/162850/files/DZNE-2021-01505.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:162850
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9001203
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-29
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b ACTA NEUROPATHOL : 2021
|d 2022-11-29
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA NEUROPATHOL : 2021
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-29
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2021-01-29
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-29
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-29
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-29
920 1 _ |0 I:(DE-2719)1013026
|k AG Stöcker
|l MR Physics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013026
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21